Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.
Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 16, 2022 | Series C | $75M | 1 | ARCH Venture Partners | — | Detail |
Dec 15, 2022 | Series C | $75M | 17 | ARCH Venture Partners | — | Detail |
Feb 4, 2022 | Funding Round | — | 1 | Max Hodak | — | Detail |
Jun 3, 2021 | Series B | $40M | 12 | Khosla Ventures | — | Detail |
Apr 4, 2017 | Series A | $10M | 2 | Neurotechnology Investors | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
ARCH Venture Partners | Yes | Series C |
Max Hodak | Yes | Funding Round |
Alumni Ventures | — | Series C |
Bezos Expeditions | — | Series C |
Forepont Capital Partners | — | Series C |
Gates Frontier fund | — | Series C |
General Advance | — | Series C |
Greenoaks | — | Series C |
ID8 Investments | — | Series C |
Khosla Ventures | — | Series C |